{
    "2021-10-14": [
        [
            {
                "time": "",
                "original_text": "沪深港通资金医药股流向数据库",
                "features": {
                    "keywords": [
                        "沪深港通",
                        "资金",
                        "医药股",
                        "流向",
                        "数据库"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：新冠小分子药MOLNUPIRAVIR进展迅速 关注相关产业投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠",
                        "小分子药",
                        "MOLNUPIRAVIR",
                        "进展",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "新冠系列专题深度(二)：Q4窗口期 看好新冠口服药物及其CDMO投资机遇",
                "features": {
                    "keywords": [
                        "新冠",
                        "系列专题",
                        "Q4",
                        "窗口期",
                        "口服药物",
                        "CDMO",
                        "投资机遇"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}